. . . . . . . "[Oncotype DX(\uFFFD) is a multigene assay that provides prognostic information in terms of 10-year distant recurrence and predicts the likelihood of adjuvant chemotherapy benefit in estrogen receptor positive breast cancer patients, based on the expression of a panel of 21\uFFFDgenes (16\uFFFDcancer-related and five reference genes) from a tumor specimen (core biopsy or surgical resection).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:29+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .